Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for RxSight (RXST) over the last 5 years, with Q3 2025 value amounting to 0.16%.

  • RxSight's Return on Invested Capital fell 200.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.17% for FY2024, which is 1800.0% up from last year.
  • As of Q3 2025, RxSight's Return on Invested Capital stood at 0.16%, which was down 200.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, RxSight's Return on Invested Capital registered a high of 1.13% during Q3 2021, and its lowest value of 0.48% during Q4 2022.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.29% (2024), whereas its average is 0.2%.
  • Per our database at Business Quant, RxSight's Return on Invested Capital crashed by -15700bps in 2022 and then surged by 1800bps in 2024.
  • Over the past 5 years, RxSight's Return on Invested Capital (Quarter) stood at 0.29% in 2021, then plummeted by -66bps to 0.48% in 2022, then soared by 35bps to 0.31% in 2023, then soared by 58bps to 0.13% in 2024, then fell by -24bps to 0.16% in 2025.
  • Its Return on Invested Capital was 0.16% in Q3 2025, compared to 0.15% in Q2 2025 and 0.13% in Q1 2025.